Antioxidants attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells

Jau-Shyang Huang1, Lea-Yea Chuang, Jinn-Yuh Guh

  • 1Department of Biological Science and Technology, Chung Hwa University of Medical Technology, Tainan, Taiwan, ROC. jaushyang12@hotmail.com

Insights

N-acetylcysteine (NAC) and taurine combat high glucose-induced kidney cell growth and hypertrophy in diabetic nephropathy. These antioxidants inhibit key signaling pathways and reduce fibronectin and collagen levels.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Nephrology

Background:

  • Diabetic nephropathy (DN) involves hyperglycemia-driven oxidative stress, leading to renal tubular hypertrophy.
  • The precise mechanisms by which antioxidants inhibit hypertrophy in DN are not fully understood.

Purpose of the Study:

  • To investigate the effects of N-acetylcysteine (NAC) and taurine on renal tubular epithelial cells experiencing high glucose.
  • To elucidate the molecular pathways targeted by NAC and taurine in mitigating hypertrophy.

Main Methods:

  • Cultured renal tubular epithelial cells were exposed to high glucose conditions.
  • The impact of NAC and taurine on cellular growth, hypertrophy, signaling pathways (Raf-1/MAPK, JAK2/STAT), cell cycle regulators, and extracellular matrix proteins was assessed.

Main Results:

  • NAC and taurine significantly reduced high glucose-induced cellular hypertrophy and inhibited the activation of Raf-1/MAPK and JAK2-STAT1/STAT3 signaling pathways.
  • These antioxidants modulated cell cycle proteins, increasing cyclin D1/cdk4 and decreasing p21/p27 expression.
  • NAC and taurine suppressed high glucose-stimulated fibronectin and type IV collagen production without inducing apoptosis.

Conclusions:

  • NAC and taurine effectively attenuate high glucose-induced hypertrophic growth in renal tubular epithelial cells.
  • Their protective effects involve the inhibition of specific signaling cascades and extracellular matrix deposition, offering potential therapeutic strategies for diabetic nephropathy.